- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Proteochemometric modeling of HIV protease susceptibility ; volume:9 ; number:1 ; day:10 ; month:4 ; year:2008 ; pages:1-11 ; date:12.2008
BMC bioinformatics ; 9, Heft 1 (10.4.2008), 1-11, 12.2008
- Creator
-
Lapins, Maris
- Contributor
-
Eklund, Martin
Spjuth, Ola
Prusis, Peteris
Wikberg, Jarl ES
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-9-181
- URN
-
urn:nbn:de:1111-201602171955
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.05.1825, 6:21 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lapins, Maris
- Eklund, Martin
- Spjuth, Ola
- Prusis, Peteris
- Wikberg, Jarl ES
- SpringerLink (Online service)
Other Objects (12)
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease